The relationship between effectiveness and costs measured by a risk-adjusted case-mix system: multicentre study of Catalonian population data bases
- Costs of pulmonary NTM infections in Canada "substantial.". // PharmacoEconomics & Outcomes News;10/30/2010, Issue 615, p9
The article discusses research on the costs of treating pulmonary nontuberculosis mycobacterial (NTM) infections in Canada, which references the study "The Cost of Medical Management of Pulmonary Nontuberculous Mycobacterial Diseases in Ontario, Canada," by A. Leber at al, published in the...
- BC debates efficacy of physician incentives. Glauser, Wendy // CMAJ: Canadian Medical Association Journal;10/7/2014, Vol. 186 Issue 14, p521
The article focuses on a study which examined trends in access to primary care in Canada during the 12 years that led to the launch of incentives by the General Practice Services Committee (GPSC). It noted the goal of the incentives and the specific incentives awarded to patients and providers....
- Survey: Increasing Operating Costs Top List of Challenges for Medical Practices. // American Family Physician;9/15/2013, Vol. 88 Issue 6, p360
The article discusses a survey of medical practice executives conducted by the MGMA-ACMPE published in the July 2013 issue of "Connexion," which found that increasing operating costs topped the list for the challenges faced by medical practices.
- Illness, medical expenditure and household consumption: observations from Taiwan. Kuangnan Fang; Chi Ma; Yefei Jiang; Linglong Ye; Benchang Shia; Shuangge Ma // BMC Public Health;2013, Vol. 13 Issue 1, p1
Background: Illness conditions lead to medical expenditure. Even with various types of medical insurance, there can still be considerable out-of-pocket costs. Medical expenditure can affect other categories of household consumptions. The goal of this study is to provide an updated empirical...
- Novel Pharmacologic Approaches to the Management of Sepsis: Targeting the Host Inflammatory Response. Wheeler, Derek S.; Zingarelli, Basilia; Wheeler, William J.; Wong, Hector R. // Recent Patents on Inflammation & Allergy Drug Discovery;Jun2009, Vol. 3 Issue 2, p96
Sepsis is currently the 10th leading cause of death overall and accounts for significant healthcare expenditures in the developed world. There are now more deaths attributable to sepsis than coronary artery disease, stroke, or cancer, and it is widely believed that the incidence of sepsis and...
- SUBOPTIMAL BREASTFEEDING LEADS TO EXCESS COSTS, DEATHS. BURKE, MICHAEL G. // Contemporary Pediatrics;Jun2010, Vol. 27 Issue 6, p14
This article focuses on a study which examined the differential incidence of disease in breastfed and nonbreastfed infants, as well as the associated costs in 2005. It cites some of the diseases in infants that can be prevented with any or exclusive breastfeeding. The study also examined both...
- Most spending for high-cost Medicare patients not preventable through better care. // Hem/Onc Today;7/25/2013, Vol. 14 Issue 14, p60
The article discusses research led by Karen E. Joynt at Brigham and Women's Hospital which assessed costs for acute care and emergency department (ED) visits associated with Medicare patients, published in a 2013 issue of the "Journal of the American Medical Association."
- Home-based primary care cuts costs in frail US elderly. // PharmacoEconomics & Outcomes News;Aug2014, Vol. 709 Issue 1, p5
The article discusses research on the impact of home-based primary care (HBPC) model on health care costs and clinical outcomes, by K. Eric De Jonge and colleagues, published in the "Journal of the American Geriatrics Society."
- Apixaban most cost effective option in the UK. // PharmacoEconomics & Outcomes News;8/20/2011, Issue 635, p5
The article focuses on a study which compared the cost effectiveness of apixaban with enoxaparin sodium and dabigatran etexilate in preventing thromboembolism in patients undergoing total hip or total knee replacement in Great Britain.